Rosenblum Mark J 4/A
4/A · Salarius Pharmaceuticals, Inc. · Filed Dec 12, 2022
Insider Transaction Report
Form 4/AAmended
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Common Stock
2022-11-03$1.73/sh+1,488$2,580→ 7,419 total
Footnotes (1)
- [F1]The Reporting Person's previous Form 4 filed on November 7, 2022 and amended on November 8, 2022 incorrectly reported the Reporting Person acquiring 7,314 shares of common stock under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c), when it should have been reported as 1,488 shares of common stock.